Pear Therapeutics, Inc., a pioneering leader in the digital therapeutics industry, is headquartered in the United States. Founded in 2013, the company has made significant strides in developing prescription digital therapeutics designed to treat various mental health and substance use disorders. With a focus on evidence-based solutions, Pear Therapeutics offers unique products such as reSET and reSET-O, which integrate seamlessly with traditional therapies to enhance patient outcomes. These innovative offerings set the company apart in a rapidly evolving market, positioning it as a key player in the intersection of technology and healthcare. Recognised for its commitment to advancing therapeutic options, Pear Therapeutics continues to shape the future of treatment through its cutting-edge digital solutions, addressing critical needs in patient care.
How does Pear Therapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Pear Therapeutics, Inc.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pear Therapeutics, Inc., headquartered in the US, currently does not have publicly available carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As of now, Pear Therapeutics has not cascaded any emissions data from a parent or related organisation, nor does it appear to have established any industry-standard climate initiatives such as Science Based Targets (SBTi) or commitments to renewable energy (RE100). In the context of the healthcare and technology sectors, it is increasingly important for companies to develop and disclose their climate strategies to align with global sustainability goals. However, without specific emissions data or commitments, it is challenging to assess Pear Therapeutics' current environmental impact or future climate initiatives.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pear Therapeutics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.